Idiopathic pulmonary fibrosis: Aberrant recapitulation of developmental programs?
2008
Idiopathic Pulmonary Fibrosis and Developmental Pathways
publication
Evidence: moderate
Author Information
Author(s): Moisés Selman, Annie Pardo, Naftali Kaminski
Primary Institution: Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico
Hypothesis
Idiopathic pulmonary fibrosis (IPF) may result from aberrant activation of developmental pathways involved in lung development.
Conclusion
The study suggests that IPF is characterized by the aberrant activation of developmental pathways, which may lead to new therapeutic strategies.
Supporting Evidence
- IPF lungs show up-regulation of genes associated with lung development.
- Embryonic signaling pathways may be aberrantly activated in IPF.
- Epithelial-to-mesenchymal transition may contribute to fibroblast expansion in IPF lungs.
- Understanding these pathways could lead to new treatments for IPF.
Takeaway
Idiopathic pulmonary fibrosis is a serious lung disease where the body mistakenly activates pathways meant for development, causing lung damage.
Methodology
The study utilized gene expression studies and animal models to analyze the pathways involved in IPF.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website